More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-13 of 13 results

  • www.revanatx.com
  • 1
  • 25
Re-Vana Therapeutics is a pioneering ocular drug delivery and therapeutic company focused on developing the world's first sustained-release large molecule biologics to treat serious eye diseases. Our innovative platform technologies, EyeLief®,..
Relevance: 138.74434
  • www.scintipharma.com
  • 2
  • 1
SCINTIPHARMA, Inc. is a privately held company focused on problem solving in the field of pharmaceutical dosage form development. The company's main objective is to provide services to the pharmaceutical industry for the optimization of drug delivery..
Relevance: 57.625298
  • perfusetherapeutics.com
  • 2
  • 26
Perfuse Therapeutics is a clinical-stage biopharmaceutical company committed to reducing the incidence of blindness. Our mission is to develop novel therapeutics to protect and improve the vision of patients with ocular diseases... Perfuse..
Relevance: 56.47048
  • www.spinnakerbiosciences.com
  • 2
Spinnaker Biosciences is developing porous silicon, porous silicon oxide, and porous silicon/polymer composite materials with uniquely designed optical, chemical, and structural features that make ideal controlled release drug delivery vehicles...
Relevance: 53.035454
  • www.sivaklab.com
  • 1
  • 1
  • 1
To study this problem, the Sivak laboratory uses advanced molecular, biochemical, and genetic techniques to investigate tissue maintenance and repair mechanisms in the eye. In parallel, the lab maintains an interest in ocular pharmacology and drug..
Relevance: 47.46601
  • betaliq.com
Betaliq is developing a global portfolio of topical glaucoma treatments based on the unique EyeSol® topical delivery system developed by Novaliq, GMBH. Our unique water-free eye drop technology offers increased residency time and enhanced absorption..
Relevance: 47.409294
  • citrustherapeutics.com
  • 5
  • 3
Citrus Therapeutics, LLC, a manufacturer of innovative therapies and an early leader in novel multi-pharmacophore agents for AMD treatment, announces that the U.S. Patent Office has issued Patent Application No. 17/837,917 for the "Therapeutic Agent..
Relevance: 38.141335
  • www.delphisci.com
  • 1
  • 1
  • 2
Delphi Scientific utilizes nanotechnology and particle engineering to enhance or enable the delivery of pharmaceuticals and biologics. We work across therapeutic areas and delivery methods: cancer drugs, vaccine adjuvants, anesthetics, nucleic acid..
Relevance: 33.193108
  • www.attack-covid.com
  • 5
  • 13
To be prepared, we are also training the next generation of antiviral therapies. Thus, we have a training pipeline to complement our drug delivery pipeline. Our training will provide the skills and hands-on tools needed to develop the next generation..
Relevance: 32.72464
  • www.biotheravision.com
  • 1
BioTheraVision, Inc. (BTV) is a privately held, pre-clinical stage pharmaceutical company focused on developing ophthalmic therapeutics. Our approach is to repurpose known molecules through unleashing hidden potentials to treat ocular diseases where..
Relevance: 30.82566
  • www.revanatx.com
  • 2
  • 2
  • 24
Re-Vana Therapeutics is a 2016 start-up based on a technology developed at Queen's University Belfast (QUB), Northern Ireland, UK. QUB has recently been recognized as the No. 1 university in the UK for their capacity to commercialize research*. The..
Relevance: 27.118317
  • surfaceophthalmics.com
  • 8
Surface Ophthalmics, Inc. is a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases. We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold..
Relevance: 27.008604
  • www.amorphexusa.com
  • 1
  • 5
Amorphex Therapeutics LLC was founded by Edward & Jeanne Ellis, Charles Leahy and Robert Thompson, each with extensive successful experience in ophthalmic product development. They created Amorphex to develop and license products for sustained..
Relevance: 22.782402